Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
4.390
-0.060 (-1.35%)
Apr 30, 2025, 3:00 PM CST
SHA:600572 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 11,067 | 11,680 | 12,979 | 12,156 | 12,850 | 12,105 | Upgrade
|
Market Cap Growth | -10.01% | -10.01% | 6.77% | -5.40% | 6.16% | -23.41% | Upgrade
|
Enterprise Value | 10,669 | 11,402 | 12,136 | 11,898 | 13,766 | 13,693 | Upgrade
|
Last Close Price | 4.39 | 4.66 | 4.86 | 4.45 | 4.54 | 4.28 | Upgrade
|
PE Ratio | 19.06 | 18.77 | 21.94 | 33.95 | 6.37 | 26.70 | Upgrade
|
Forward PE | - | 15.92 | 15.92 | 15.92 | 15.92 | 15.92 | Upgrade
|
PS Ratio | 1.74 | 1.79 | 1.93 | 2.03 | 1.96 | 2.05 | Upgrade
|
PB Ratio | 1.56 | 1.69 | 1.77 | 1.66 | 1.68 | 2.26 | Upgrade
|
P/TBV Ratio | 1.71 | 1.86 | 2.00 | 1.92 | 1.93 | 2.71 | Upgrade
|
P/FCF Ratio | 14.76 | 16.18 | 18.82 | 14.07 | 41.48 | 15.34 | Upgrade
|
P/OCF Ratio | 11.05 | 11.54 | 14.44 | 10.52 | 14.42 | 9.69 | Upgrade
|
PEG Ratio | - | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 | Upgrade
|
EV/Sales Ratio | 1.67 | 1.75 | 1.80 | 1.98 | 2.10 | 2.32 | Upgrade
|
EV/EBITDA Ratio | 10.45 | 10.81 | 11.99 | 12.35 | 14.39 | 16.15 | Upgrade
|
EV/EBIT Ratio | 16.22 | 15.96 | 17.31 | 17.23 | 20.42 | 23.55 | Upgrade
|
EV/FCF Ratio | 14.23 | 15.80 | 17.60 | 13.78 | 44.43 | 17.35 | Upgrade
|
Debt / Equity Ratio | 0.06 | 0.06 | 0.17 | 0.16 | 0.20 | 0.42 | Upgrade
|
Debt / EBITDA Ratio | 0.40 | 0.40 | 1.22 | 1.24 | 1.55 | 2.66 | Upgrade
|
Debt / FCF Ratio | 0.59 | 0.59 | 1.80 | 1.39 | 4.82 | 2.85 | Upgrade
|
Asset Turnover | 0.62 | 0.62 | 0.61 | 0.54 | 0.64 | 0.62 | Upgrade
|
Inventory Turnover | 2.35 | 2.35 | 2.30 | 2.27 | 2.62 | 1.87 | Upgrade
|
Quick Ratio | 1.22 | 1.22 | 1.38 | 1.49 | 1.37 | 0.95 | Upgrade
|
Current Ratio | 1.76 | 1.76 | 1.82 | 1.93 | 1.73 | 1.27 | Upgrade
|
Return on Equity (ROE) | 9.23% | 9.23% | 9.20% | 6.15% | 32.90% | 10.67% | Upgrade
|
Return on Assets (ROA) | 4.22% | 4.22% | 3.95% | 3.89% | 4.10% | 3.80% | Upgrade
|
Return on Capital (ROIC) | 5.61% | 5.61% | 5.12% | 4.89% | 5.04% | 4.62% | Upgrade
|
Return on Capital Employed (ROCE) | 9.70% | 9.70% | 8.70% | 8.50% | 8.30% | 9.70% | Upgrade
|
Earnings Yield | 5.38% | 5.33% | 4.56% | 2.95% | 15.70% | 3.74% | Upgrade
|
FCF Yield | 6.77% | 6.18% | 5.31% | 7.11% | 2.41% | 6.52% | Upgrade
|
Dividend Yield | 4.56% | - | 4.12% | 3.37% | 3.52% | - | Upgrade
|
Payout Ratio | 86.93% | 84.11% | 71.02% | 136.92% | 4.21% | 31.50% | Upgrade
|
Buyback Yield / Dilution | 3.20% | 3.46% | -0.81% | 1.10% | -2.71% | 5.28% | Upgrade
|
Total Shareholder Return | 7.76% | 3.46% | 3.31% | 4.47% | 0.82% | 5.28% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.